DDA1 and colonic neoplasm: We observed that DDA1 predicts tumor recurrence and poor prognosis in patients with stage II colon cancer, especially for patients with stage IIB–IIC disease undergoing post-operative chemotherapy with 5-FU/LV or FOLFOX4.